Angiotensin II (Ang II), the main peptide of the renin-angiotensin
|
|
- Florence Allison
- 5 years ago
- Views:
Transcription
1 Connective Tissue Growth Factor Is a Mediator of Angiotensin II Induced Fibrosis Mónica Rupérez, BSc; Óscar Lorenzo, PhD; Luis Miguel Blanco-Colio, PhD; Vanesa Esteban, BSc; Jesús Egido, MD; Marta Ruiz-Ortega, PhD Background Angiotensin II (Ang II) participates in the development of fibrosis during vascular damage. Connective tissue growth factor (CTGF) is a novel fibrotic mediator. However, the potential link between CTGF and Ang II has not been investigated. Methods and Results In vivo Ang II effects were studied by systemic infusion into normal rats to evaluate CTGF and extracellular matrix protein (ECM) expression by immunohistochemistry. In aorta of Ang II infused rats, CTGF staining was markedly increased and ECM overexpression was observed. An AT 1 antagonist diminished CTGF and ECM. In growth-arrested vascular smooth muscle cells, Ang II induced CTGF mrna expression after 1 hour, remained elevated up to 24 hours, and increased CTGF protein production, which was increased up to 72 hours. The AT 1 antagonist blocked Ang II induced CTGF gene and protein expression. Early CTGF upregulation is independent of new protein synthesis. Several intracellular signals elicited by Ang II are involved in CTGF synthesis, including protein kinase C activation, reactive oxygen species, and transforming growth factor- endogenous production. Incubation with a CTGF antisense oligonucleotide decreased CTGF and fibronectin upregulation caused by Ang II. Conclusions Our results show that Ang II, via AT 1, increases CTGF in vascular cells both in vivo and in vitro. This novel finding suggests that CTGF may be a mediator of the profibrogenic effects of Ang II in vascular diseases. (Circulation. 2003;108: ) Key Words: angiotensin muscle, smooth cardiovascular diseases Angiotensin II (Ang II), the main peptide of the renin-angiotensin system, is a true cytokine that regulates cell growth, inflammation, and fibrosis, contributing to the progression of vascular damage. 1 3 Extracellular matrix (ECM) accumulation in the cardiovascular system is involved in vascular and cardiac hypertrophy and heart failure. Hypertension causes structural changes in the arteries, including hypertrophy of vascular smooth muscle cells (VSMCs), collagen and fibronectin (FN) accumulation, and destruction of elastic fibers. 3 ECM overproduction has been attributed to hemodynamic changes associated with mechanical stress or factors such as Ang II and transforming growth factor- (TGF- ). 3 The knowledge of molecular mechanisms involved in ECM accumulation may contribute to a better understanding of this pathological process and to improved therapeutic strategies. Connective tissue growth factor (CTGF) is a novel and potent profibrotic factor, a member of the CCN family (cysteine-rich61, CTGF, and nephroblastoma overexpressed) of early immediate genes. CTGF is implicated in fibroblast proliferation, cellular adhesion, angiogenesis, and ECM synthesis. This protein of 38 kda was originally identified in conditioned media from human umbilical vein endothelial cells and mice fibroblasts, primarily on the cell surface and ECM. 4 CTGF participates in fibrotic processes, including skin disorders, tumor development, and renal disease. 4 CTGF is overexpressed in human atherosclerotic lesions 5 and in the myocardium of infarcted rats and patients with cardiac ischemia. 6,7 In VSMCs, the cells primarily involved in ECM production, CTGF regulates cell proliferation/apoptosis, migration, and fibrosis. 4,7 9 For this reason, studies defining its role in vascular damage are necessary. CTGF expression is regulated by several agents, including TGF-, tumor necrosis factor-, camp, high glucose, dexamethasone, factor VIIa, and mechanical stress, but not by growth factors, such as endothelial growth factor, plateletderived growth factor, and fibroblast growth factor. 4 It has been postulated that CTGF is a downstream mediator of the effect of TGF- on ECM regulation and apoptosis. 4,10,11 In different pathological settings and cell types, Ang II regulates TGF- expression and could mediate some Ang II responses. 3,12 However, the relation between CTGF and Ang II has not been studied. Our aim was to investigate mediators and molecular mechanisms involved in Ang II induced fibrosis associated with vascular damage, evaluating the hypothesis that CTGF could be a mediator of Ang II actions. Received March 29, 2002; de novo received March 25, 2003; revision received May 30, 2003; accepted June 3, From the Vascular and Renal Research Laboratory, Autónoma University, Fundación Jiménez Diaz, Universidad Autónoma, Madrid, Spain. Correspondence to Marta Ruiz-Ortega, Vascular and Renal Research Laboratory, Autónoma University, Fundación Jiménez Díaz, Avda Reyes Católicos, 2, Madrid, Spain. mruizo@fjd.es 2003 American Heart Association, Inc. Circulation is available at DOI: /01.CIR BA 1499
2 1500 Circulation September 23, 2003 Figure 1. Ang II infusion increases production of CTGF, FN, type I collagen, and laminin in rat aorta. Rats were infused with Ang II (50 ng kg 1 min 1 ) for 3 and 7 days. One group was treated with losartan (AT 1 antagonist, 10 mg kg 1 d 1 ) for 7 days. Aortic samples were analyzed by immunohistochemistry. Figures show a representative animal of 8 studied in each group. Magnification 400. Methods Ang II (50 ng kg 1 min 1 by subcutaneous osmotic minipumps, n 8 rats each group) was infused systemically into female Wistar rats. 13 One group was treated with the AT 1 antagonist losartan (10 mg kg 1 d 1 in the drinking water) starting 24 hours before Ang II infusion and studied after 7 days. Animals were anesthetized with 5 mg/kg xylazine (Rompun, Bayer AG) and 35 mg/kg ketamine (Ketolar, Fisher) according to European guidelines. VSMCs from rat thoracic aorta were obtained 14 and serum-starved for 48 hours before use. Gene and Protein Studies Gene expression was analyzed by reverse transcription polymerase chain reaction (RT-PCR) and Northern blot. 15 For in vivo studies, paraffin-embedded sections of rat aorta were studied by immunohistochemistry. 13 Antibodies used were rabbit anti-ctgf (Torrey Pines Biolaboratories), anti-fn (Chemicon International), anti-collagen type I (Calbiochem), anti-laminin (Neomarkers), and peroxidaseconjugated secondary antibodies (Amersham). Negative controls without the primary antibody or using an unrelated antibody were included to check for nonspecific staining. For in vitro studies, cells were fixed in methanol/acetone at 20 C. In VSMCs, protein levels were also determined by Western blot. 14 Statistical Analysis Results are expressed as n-fold increase over control in densitometric arbitrary units as mean SEM of experiments made. Significance was established with GraphPAD Instat using Student s t test (Graph- PAD Software), Wilcoxon, and Student-Newman-Keuls test. Differences were considered significant at a value of P Results Systemic Infusion of Ang II Increases CTGF Expression in Aorta The aortic samples from control rats did not present staining for CTGF (Figure 1). In normal human arteries, CTGF mrna or protein could not be detected. 5 In rats infused with Ang II for 3 days, CTGF production was induced, showing positive immunostaining in VSMCs, which remained elevated after 7 days (Figure 1). In human arteries with atherosclerotic lesions, high CTGF expression was found in intimal VSMCs of areas with ECM and fibrosis. 5 Accumulation of several ECM proteins involved in vascular damage, such as FN, type I collagen, and laminin, were found in the aorta of Ang II infused rats
3 Rupérez et al Ang II Increases Vascular CTGF 1501 Figure 2. Ang II increases CTGF mrna expression (A) and protein production (B, C) in cultured VSMCs. Growth-arrested VSMCs were stimulated with 10 7 mol/l Ang II, 1 ng/ml TGF-, and 10 7 mol/l PMA for different times. A, Left, representative Northern blot of 8 performed; right, values of mean SEM. *P 0.05 vs control. B, Representative Western blot (left) and values of total CTGF production (mean SEM of 5 experiments; right). Black bars represent Ang II, white bars, TGF-. Results of total CTGF mrna or production were obtained from densitometric analysis and expressed as ratio CTGF/G3PDH or CTGF/tubuline, respectively, as n-fold increase over control. *P 0.05 vs control. C, Immunocytochemical staining of CTGF in VSMCs. Figure shows a representative experiment of 3 performed. (Figure 1), as described previously. 16 This effect was observed only after 7 days of Ang II infusion but not after 3 days (showed only in FN deposition), demonstrating that CTGF induction occurs earlier than ECM overproduction and suggesting that CTGF could be a mediator of vascular fibrosis caused by Ang II. The AT 1 antagonist losartan abolished blood pressure elevation observed in Ang II infused rats (103 2 versus mm Hg, n 8, P 0.05 versus Ang II at day 7) and aortic CTGF and ECM protein overexpression (Figure 1), suggesting that Ang II, through the AT 1 receptor, induces CTGF and fibrosis in vivo. Angiotensin II Increases CTGF mrna and Protein Levels in VSMCs Growth-arrested VSMCs expressed low CTGF mrna levels, as shown by Northern blot as a band of 2.4 kb. Ang II stimulation rapidly increased CTGF mrna (3.3-fold, 10 7 mol/l; 1 hour, Figure 2A), which was maximal after 3 hours and decreased thereafter, but showed another peak at longer times. Data were confirmed by RT-PCR (not shown). CTGF protein production was investigated with an anti-ctgf antibody that recognizes the 247 to 260 CTGF amino acids (Figure 2B). In growth-arrested VSMCs, only the cell-associated fraction expressed a band of 38 kda, the apparent CTGF molecular weight, which was undetectable in the supernatant. Ang II increased total cellular CTGF levels (cytosolic and cell-associated) and the release into the extracellular medium (soluble fraction) after 24 hours of treatment, remaining elevated up to 72 hours. Immunocytochemistry showed that growth-arrested VSMCs presented a slight CTGF staining, and stimulation for 48 hours with Ang II or 10% FCS (positive control)
4 1502 Circulation September 23, 2003 Figure 3. Ang II increases CTGF mrna (A) and protein levels (B) via AT 1 in VSMCs. Cells were pretreated for 45 minutes with 10 6 mol/l losartan (AT 1 antagonist) or 10 5 mol/l PD (AT 2 antagonist) and then stimulated with 10 7 mol/l Ang II for 24 hours. A, Representative Northern blot and mean SEM of 5 experiments (bottom). B, Representative Western blot of CTGF and mean SEM of 4 experiments (bottom). *P 0.05 vs control. #P 0.05 vs Ang II. clearly increased cytoplasmic staining (Figure 2C). These data suggest that in VSMCs, Ang II increases CTGF mrna and protein production. Angiotensin II Increases CTGF via AT 1 in VSMCs In VSMCs, Ang II acts through 2 specific receptors, AT 1 and AT 2. 2,14 The AT 1 antagonist losartan caused a significant diminution in Ang II induced CTGF at both the mrna and protein levels (Figure 3), whereas the AT 2 antagonist PD had no effect, suggesting that Ang II induced CTGF upregulation is mediated through AT 1 receptors. Figure 4. Molecular mechanisms involved in Ang II induced CTGF regulation. A, Cells were preincubated for 1 hour with inhibitors of RNA synthesis (actinomycin D [Act D], 1 g/ml) or protein synthesis (cycloheximide [CHX], 1 g/ml) and stimulated with 10 7 mol/l Ang II for 1 hour, and mrna was analyzed by Northern blot. B, In other experiments, cells were pretreated with inhibitors of PKC (bisindolylmaleimide [BIP] and H7; 10 6 mol/l), PTK (genistein and erbstatin; 10 6 mol/l), and antioxidants (diphenyleneiodonium [DPI], 10 5 mol/l and Tiron, 5 mmol/l) and studied by Western blot. Cells were treated with 10 7 mol/l Ang II for 24 hours. PMA (10 7 mol/l) was used as PKC activator. Figures show a representative experiment of 4 to 5 performed. Molecular Mechanisms of Ang II Induced CTGF Gene and Protein Production CTGF gene is regulated by Ang II in a 2-phase manner, a rapid induction after 1 hour and a maintained response until 24 hours (Figure 2). Pretreatment with actinomycin D, an inhibitor of RNA synthesis, markedly reduced CTGF mrna induced by Ang II at different times studied, between 1 and 24 hours (Figure 4A). When ActD was added in the last 2 hours of incubation, Ang II induced CTGF gene expression after 18 hours was also inhibited (not shown), suggesting that CTGF overexpression in Ang II treated cells was a result of newly synthesized mrna. Protein synthesis inhibition by cycloheximide strongly increased CTGF mrna expression in basal and Ang II treated cells at all times studied (Figure 4A). Our data demonstrate that early CTGF upregulation caused by Ang II is independent of the de novo protein synthesis of cytokines and transcription factors, showing that CTGF behaves as an early responsive gene as occurs in other cell types. 17 Ang II, via AT 1, activates several intracellular mediators, including protein kinase C (PKC), phosphotyrosine kinases (PTK), and production of intracellular reactive oxygen species (ROS). 2 In VSMCs, the PKC activator phorbol 12-myristate 13-acetate (PMA) increased CTGF expression and synthesis (Figure 2). Two PKC inhibitors, H-7 and bisindolylmaleimide, reduced the stimulatory effect of Ang II on CTGF production. PTK inhibitors slightly but not signifi-
5 Rupérez et al Ang II Increases Vascular CTGF 1503 Figure 5. H 2 O 2 increases CTGF mrna and protein expression independently of TGF-. Cells were treated with 200 mol/l H 2 O 2. TGF- was blocked with a TGF- neutralizing antibody (Ab; 10 g/ml) or 10 6 mol/l Decorin. A, Representative Northern blot; B, Western blot of 3 performed. Figure 6. TGF- is involved in Ang II induced CTGF gene expression (A) and synthesis (B, C). Cells were cotreated with Ang II and a TGF- neutralizing antibody (Ab; 10 or 1 g/ml) or Decorin. A, Representative RT-PCR of 3 performed; B, representative Western blots of 3 to 4 performed. cantly diminished Ang II mediated CTGF (Figure 4B). In VSMCs, exogenous H 2 O 2 increases CTGF mrna expression and protein production (Figure 5). The NADH/NADPH oxidase inhibitor diphenyleneiodonium and the O 2 scavenger Tiron markedly diminished Ang II induced CTGF protein production (Figure 4B). CTGF gene upregulation after 18 hours was diminished by all of these inhibitors (not shown), indicating that CTGF is regulated at the transcription level. These data suggest that Ang II, via AT 1 through the activation of several protein kinases such as PKC and by a redoxsensitive mechanism, regulates CTGF protein production. In VSMCs, TGF- upregulates CTGF mrna expression and protein synthesis (Figure 2). Compared with Ang II, TGF- upregulates the CTGF gene with a similar kinetic response but causes a higher increase in CTGF gene expression at shorter times, whereas after 24 hours, the response was similar. TGF- increased CTGF synthesis earlier than Ang II, showing augmented protein synthesis after 6 hours (Figure 2B). We blocked TGF- actions by different methods: a neutralizing antibody against active TGF- that blocks Ang II induced ECM production 18 and decorin, a scavenger of its active form. 12 These TGF- blockers inhibited Ang II induced CTGF mrna overexpression at 18 and 24 hours and diminished CTGF production from 24 to 72 hours (Figure 6), suggesting that endogenous TGF- synthesis is involved, at least in part, in CTGF production caused by Ang II. In contrast, TGF- blockade did not modify Ang II induced CTGF mrna expression at 1 hour (Figure 6A), showing that early CTGF upregulation is independent of TGF-. We have also observed that CTGF overproduction caused by exogenous H 2 O 2 was not diminished by TGF- blockade (Figure 5), showing a TGF- independent CTGF regulation in VSMCs, as observed in other cells. 19 Role of CTGF in Ang II Induced Fibrosis In cultured cells, Ang II increased FN production in both the cell-associated and the soluble fractions. 18,20 We therefore investigated whether CTGF was involved in Ang II induced fibrosis, evaluating the effect on soluble FN production by Western blot in VSMCs. To block CTGF actions, we used a CTGF antisense oligonucleotide, constructed with a 16-mer derived from the starting translation site, which contains the initial ATG whose sequence is 5 -TACTGGCGGCGGTCAT-3, which blocks TGF- actions. 10 In VSMCs, incubation with the CTGF antisense oligonucleotide diminished Ang II induced FN production (Figure 7). Recombinant CTGF may induce its own synthesis. 15 As a control, we have observed that the presence of CTGF antisense oligonucleotide abolished Ang II induced CTGF mrna expression (not shown). These data suggest that CTGF is a downstream mediator of Ang II induced FN upregulation and fibrosis. Discussion Hypertension is a risk factor for the development of coronary diseases and atherosclerosis. Fibrosis is one of the vascular changes caused by hypertension. 1 3 In a rat model of hypertension induced by cyclosporin A (CsA) and high-sodium diet, the enhanced expression of CTGF in epicardial arteries was closely correlated with blood pressure elevation. 21 Mechanical strain could be responsible for CTGF upregulation in hypertensive animals, because cyclic mechanical stretching induced CTGF, and increased immunoreactive Ang II in the culture medium and ECM synthesis. 15,22 However, in the CsA model, the AT 1 antagonist only partially diminished blood
6 1504 Circulation September 23, 2003 Figure 7. CTGF is involved in Ang II induced FN production. VSMCs were treated with 10 7 mol/l Ang II for 48 hours, and soluble FN was determined by Western blot. To neutralize CTGF actions, we used a CTGF antisense oligonucleotide (ODN; 20 g/ml) added directly to medium, and CTGF sense ODN was its control. As positive control of FN production, 10% FCS was used. Values of mean SEM of 4 experiments are shown in lower panel. *P 0.05 vs control. #P 0.05 vs Ang II. pressure and the development of left ventricular hypertrophy, whereas it normalized cardiac CTGF. 21 We have observed that systemic infusion of Ang II into rats, which only slightly increased blood pressure, caused a marked aortic CTGF induction and vascular fibrosis. Moreover, in vitro, Ang II increases CTGF gene expression and production, showing that Ang II caused a direct, non pressure-mediated CTGF upregulation. CTGF overexpression occurs in the active phase of matrix synthesis during wound repair. 4 Our in vivo data show a similar behavior. In Ang II infused rats, CTGF induction is prolonged for at least 7 days, when ECM overexpression was observed. In cultured VSMCs, an antisense CTGF oligonucleotide diminished Ang II induced FN production, demonstrating that CTGF is involved in vascular fibrosis caused by Ang II. Ang II acts through its binding to specific receptors. 2 AT 1 regulates cell proliferation and production of cytokines and ECM proteins and some pathological processes, including Ang II induced hypertension, neointimal formation, and cardiac hypertrophy. 1 3 However, other processes are controlled by AT 2, such as cell growth inhibition and inflammatory cell recruitment. 1,2 We have observed that in cultured VSMCs, Ang II increased CTGF expression and synthesis via AT 1. Moreover, in Ang II infused rats, the AT 1 antagonist losartan diminished aortic CTGF and ECM overexpression. The aortic FN upregulation was not a result of blood pressure elevation but rather primarily of AT Our data clearly demonstrate that Ang II via AT 1 could contribute to vascular damage increasing fibrosis through CTGF upregulation. The molecular mechanisms linked to AT 1 activation are common to classic cytokines and include activation of several kinases. 2 Among the intracellular signaling systems involved in Ang II induced matrix regulation, PKC and PTK activation play an important role in different cell types. 18,20 In VSMCs, PKC mediated FN production caused by Ang II. 20 Our data demonstrate that in VSMCs, Ang II regulates CTGF via AT 1 and activation of PKC, whereas PTK activation made a minimal contribution. Opposite results have been described. The PI3-kinase-Akt pathway, independently of PKC, mediated vascular endothelial growth factor induced CTGF. 23 In rat kidney fibroblasts, only inhibitors of PKA but not of PKC or PTK blocked TGF- stimulated CTGF transcription. 4 CTGF expression was inhibited by phosphorylation on serine/threonine and tyrosine by PKC and PTK. 24 In VSMCs, we have observed that the PKC activator PMA increased CTGF gene and production, indicating that the PKC effect is cell specific. Ang II, via AT 1, increased H 2 O 2 generation through phospholipase D dependent, NADH/NADPH oxidase sensitive pathways. 2 Diverse antioxidants blocked CTGF production elicited by Ang II, suggesting that ROS act as intermediates of AT 1 -mediated CTGF production. ROS also mediate other Ang II effects, including cell proliferation, protein synthesis and intracellular responses, such as activation of mitogen-activated protein kinase, nuclear factor- B, and activator protein-1. 2,14 Altogether, these data suggest that Ang II, via AT 1, elicited several intracellular signals, such as PKC activation and ROS production, that contribute to CTGF and ECM regulation. TGF- is the most important regulator of ECM. 12 ACE inhibitors and AT 1 antagonists diminished tissue expression of TGF- and fibrosis, and blockade of TGF- diminished Ang II induced ECM production. 3,12,18 TGF- and Ang II share intracellular mechanisms involved in regulation of ECM and, as shown here, of CTGF, including activation of PKC and PTK. 12,17,18 The CTGF promoter contains a TGF- response element. 4 CTGF mediates several TGF- actions, 10,11 but other responses, such as changes in fibroblast morphology, are CTGF-independent. 25 Here, we demonstrate that the blockade of TGF- abolished Ang II induced CTGF gene and protein production, suggesting that endogenous TGF- synthesis is involved, at least in part, in CTGF production caused by Ang II. Intracellular ROS directly induced CTGF expression, via Janus kinase activation, independently of TGF- in epithelial cells. 19 In VSMCs, we have also observed that H 2 O 2 upregulates CTGF by a TGF- independent process. Our data demonstrate that Ang II upregulates CTGF by a process that can be mediated by production of growth factors (TGF- ) and intracellular signals (protein kinases, ROS activation), showing the complexity of Ang II responses in vascular tissue. The physiological functions of CTGF in vivo are not yet fully determined. CTGF stimulates proliferation in fibroblasts and endothelial cells, 4,26 whereas it causes VSMC apoptosis. 9 In human atherosclerotic plaques, elevated Ang II and CTGF 1 3,5 and apoptosis of VSMCs 27 were found. Ang II via AT 1 increased but via AT 2 inhibited cell proliferation. 2 An in vivo study has shown that stimulation of AT 1 or AT 2 induces apoptosis in vessels. 28 In Ang II infused rats and in cultured VSMCs, we have not observed apoptosis (data not shown), indicating that in our experimental conditions and at the times
7 Rupérez et al Ang II Increases Vascular CTGF 1505 studied, CTGF overexpression via AT 1 activation is associated with fibrosis but not with apoptosis. In cardiac interstitial fibroblasts, Ang II via AT 2 increases collagen. 29 AT 2 is involved in overload-induced cardiac hypertrophy. 30 In contrast, an AT 1 antagonist prevented CsA-induced vascular damage and cardiac CTGF and ECM overexpression. 21 TGF- induces CTGF in cardiac fibroblasts and cardiomyocytes. In both cell types, CTGF increases production of FN, collagen, and PAI-1, 7 which shows its participation in cardiac fibrosis. CTGF overexpression has also been described in cardiac ischemia, 6,7 but its role in fibrosis or apoptosis is not clear. Future studies are necessary to determine the role of Ang II receptors and CTGF in heart failure. In conclusion, our data show that Ang II in vivo and in vitro induces a novel profibrogenic factor: CTGF. In Ang II infused rats, aortic CTGF expression preceded ECM overexpression, suggesting that CTGF could be a downstream mediator of Ang II induced structural changes of the vascular wall. These data might contribute to increase our knowledge of the mechanisms underlying fibrosis in cardiovascular diseases. Acknowledgments This study was supported by grants from (FIS) (01/3130, PI , and PI020822), (CAM) (08.4/0017/2000), the Fundación Mapfre Medicina, the Sociedad Española de Nefrología, Red de Centros Cardiovascular and EU project QLG1-CT M. Rupérez, Dr Lorenzo, and V. Esteban are fellows of FIS. References 1. Ruiz-Ortega M, Lorenzo O, Suzuki Y, et al. Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens. 2001;10: Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52: Tuñon J, Ruiz-Ortega M, Egido J. Regulation of matrix proteins and impact on vascular structure. Curr Hypertens Rep. 2000;2: Lau LF, Lam SCT. The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res. 1999;248: Oemar BS, Werner A, Garnier JM, et al. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation. 1997; 18: Ohnishi H, Oka T, Kusachi S, et al. Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J Mol Cell Cardiol. 1998;30: Chen MM, Lam A, Abraham JA, et al. CTGF expression is induced by TGF-beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol. 2000;32: Fan WH, Pech M, Karnovsky MJ. Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro. Eur J Cell Biol. 2000;79: Hishikawa K, Oemar BS, Tanner FC, et al. Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells. Circulation. 1999;100: Hisikawa K, Nakaki T, Fujii T. Transforming growth factor-beta 1 induces apoptosis via connective tissue growth factor in human aortic smooth muscle cells. Eur J Pharmacol. 1999;385: Duncan MR, Frazier KS, Abramson S, et al. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by camp. FASEB J. 1999;13: Border WA, Noble NA. Interactions of transforming growth factor- and angiotensin II in renal fibrosis. Hypertension. 1998;31: Ruiz-Ortega M, Lorenzo O, Ruperez M, et al. Angiotensin II activates nuclear transcription factor B via AT 1 and AT 2 receptors in the kidney. Am J Pathol. 2001;158: Ruiz-Ortega M, Lorenzo O, Ruperez M, et al. Angiotensin II activates nuclear transcription factor B through AT 1 and AT 2 receptors in cultured vascular smooth muscle cells: molecular mechanisms. Circ Res. 2000; 23: Riser BL, Denichillo M, Cortes P, et al. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol. 2000;11: Takasaki I, Chobanian AV, Sarzani R, et al. Effect of hypertension on fibronectin expression in the rat aorta. J Biol Chem. 1990;265: Kucich U, Rosenbloom JC, Herrick DJ, et al. Signaling events required for transforming growth factor-beta stimulation of connective tissue growth factor expression by cultured human lung fibroblasts. Arch Biochem Biophys. 2001;395: Ruiz-Ortega M, Egido J. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int. 1997;52: Park SK, Kim J, Seomun Y, et al. Hydrogen peroxide is a novel inducer of connective tissue growth factor. Biochem Biophys Res Commun. 2001; 284: Tamura K, Nyui N, Tamura N, et al. Mechanism of angiotensin II-mediated regulation of fibronectin gene in rat vascular smooth muscle cells. J Biol Chem. 1998;273: Finckenberg P, Lassila M, Inkinen K, et al. Cyclosporine induces myocardial connective tissue growth factor in spontaneously hypertensive rats on high-sodium diet. Transplantation. 2001;71: Tamura K, Chen YE, Lopez-Ilasaca M, et al. Molecular mechanism of fibronectin gene activation by cyclic stretch in vascular smooth muscle cells. J Biol Chem. 2000;275: Suzuma K, Naruse K, Suzuma I, et al. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, FTL1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J Biol Chem. 2000;275: Fan WH, Karnovsky MJ. Activation of protein kinase C inhibits the expression of connective tissue growth factor. Biochem Biophys Res Commun. 2000;275: Kothapalli D, Hayashi N, Grotendorst GR. Inhibition of TGF- stimulated CTGF gene expression and anchorage-independent growth by camp identifies a CTGF-dependent restriction point in the cell cycle. FASEB J. 1998;12: Shimo T, Nakanishi T, Nishida T, et al. Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem. 1999;126: Blanco-Colio LM, Hernandez-Presa MA, Ortego M, et al. Potential role of apoptosis in atherosclerosis. Cardiovasc Risk Factors. 2000;9: Diep QN, Li JS, Schiffrin EL. In vivo study of AT 1 and AT 2 angiotensin receptors in apoptosis in rat blood vessels. Hypertension. 1999;34: Brilla CG, Zhou G, Matsubara L, et al. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol. 1994;26: Senbonmatsu T, Ichihara S, Price E Jr, et al. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J Clin Invest. 2000;106:R25 R29.
renoprotection therapy goals 208, 209
Subject Index Aldosterone, plasminogen activator inhibitor-1 induction 163, 164, 168 Aminopeptidases angiotensin II processing 64 66, 214 diabetic expression 214, 215 Angiotensin I intrarenal compartmentalization
More informationCardiovascular Protection and the RAS
Cardiovascular Protection and the RAS Katalin Kauser, MD, PhD, DSc Senior Associate Director, Boehringer Ingelheim Pharmaceutical Inc. Micardis Product Pipeline Scientific Support Ridgefield, CT, USA Cardiovascular
More informationIntroduction. Acute sodium overload produces renal tubulointerstitial inflammation in normal rats
Acute sodium overload produces renal tubulointerstitial inflammation in normal rats MI Roson, et al. Kidney International (2006) Introduction Present by Kanya Bunnan and Wiraporn paebua Tubular sodium
More informationUncovering the mechanisms of wound healing and fibrosis
Any Questions??? Ask now or contact support support@sabiosciences.com 1-888-503-3187 International customers: SABio@Qiagen.com Uncovering the mechanisms of wound healing and fibrosis Webinar related questions:
More informationEffect of simultaneous blockade of AT1 and AT2 receptors on the NF B pathway and renal inflammatory response
Kidney International, Vol. 64, Supplement 86 (2003), pp. S33 S38 Effect of simultaneous blockade of AT1 and AT2 receptors on the NF B pathway and renal inflammatory response VANESA ESTEBAN, MÓNICA RUPEREZ,
More informationInflammation in heart failure: biomarker, bystander or mediator
Inflammation in heart failure: biomarker, bystander or mediator Novel matricellular proteins to target Javier Díez, MD, PhD. Centre of Applied Medical Research and University Clinic School of Medicine,
More informationParacrine Mechanisms in Adult Stem Cell Signaling and Therapy
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy Massimiliano Gnecchi, Zhiping Zhang, Aiguo Ni, Victor J. Dzau Circulation Research 2008 Nov 21;103(11):1204-19 Introduction(1) After AMI all
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationEndotoxin Induces Toll-Like Receptor 4 Expression in Vascular Cells: A Novel Mechanism Involved in Vascular Inflammation
Endotoxin Induces Toll-Like Receptor 4 Expression in Vascular Cells: A Novel Mechanism Involved in Vascular Inflammation Introduction Feng-Yen Lin, Ph.D. 1, and Shing-Jong Lin, M.D., PhD. 2, 1 Department
More informationFull Record.
第 1 頁, 共 2 頁 Full Record Record 1 of 6 (Set #2) Title: Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes Author(s): Shyu KG, Ko WH,
More informationRenal expression of angiotensin type 2 (AT2) receptors during kidney damage
Kidney International, Vol. 64, Supplement 86 (2003), pp. S21 S26 Renal expression of angiotensin type 2 (AT2) receptors during kidney damage MARTA RUIZ-ORTEGA, VANESA ESTEBAN, YUSUKE SUZUKI, MÓNICA RUPEREZ,
More information1. Cardiomyocytes and nonmyocyte. 2. Extracellular Matrix 3. Vessels שאלה 1. Pathobiology of Heart Failure Molecular and Cellular Mechanism
Pathobiology of Heart Failure Molecular and Cellular Mechanism Jonathan Leor Neufeld Cardiac Research Institute Tel-Aviv University Sheba Medical Center, Tel-Hashomer שאלה 1 התא הנפוץ ביותר (75%~) בלב
More informationJuan Rodriguez-Vita, Marta Ruiz-Ortega, Mónica Rupérez, Vanessa Esteban, Elsa Sanchez-López, Juan José Plaza, Jesús Egido
Endothelin-1, via ET A Receptor and Independently of Transforming Growth Factor-, Increases the Connective Tissue Growth Factor in Vascular Smooth Muscle Cells Juan Rodriguez-Vita, Marta Ruiz-Ortega, Mónica
More informationTissue repair. (3&4 of 4)
Tissue repair (3&4 of 4) What will we discuss today: Regeneration in tissue repair Scar formation Cutaneous wound healing Pathologic aspects of repair Regeneration in tissue repair Labile tissues rapid
More informationIn Vivo Animal Models of Heart Disease. Why Animal Models of Disease? Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison
In Vivo Animal Models of Heart Disease Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison Why Animal Models of Disease? Heart Failure (HF) Leading cause of morbidity and mortality
More informationhemodynamic stress. A. Echocardiographic quantification of cardiac dimensions and function in
SUPPLEMENTAL FIGURE LEGENDS Supplemental Figure 1. Fbn1 C1039G/+ hearts display normal cardiac function in the absence of hemodynamic stress. A. Echocardiographic quantification of cardiac dimensions and
More informationSphingosine-1-phosphate signaling and cardiac fibrosis. Department of Physiology, Kanazawa University School of Medicine, Kanazawa, Japan
96 Special Issue: Cellular and Molecular Bases for Fibrotic Diseases Review Article Sphingosine-1-phosphate signaling and cardiac fibrosis Noriko Takuwa 1, 2, ), Yasuo Okamoto 1), Kazuaki Yoshioka 1) and
More informationPathophysiology of heart failure with preserved ejection fraction. Extracellular matrix
Pathophysiology of heart failure with preserved ejection fraction Extracellular matrix Javier Díez, MD, PhD. Full Professor of Cardiovascular Medicine and Director Division of Cardiovascular Sciences Centre
More informationc Ischemia (30 min) Reperfusion (8 w) Supplementary Figure bp 300 bp Ischemia (30 min) Reperfusion (4 h) Dox 20 mg/kg i.p.
a Marker Ripk3 +/ 5 bp 3 bp b Ischemia (3 min) Reperfusion (4 h) d 2 mg/kg i.p. 1 w 5 w Sacrifice for IF size A subset for echocardiography and morphological analysis c Ischemia (3 min) Reperfusion (8
More informationAdenosine stimulates the recruitment of endothelial progenitor cells to the ischemic heart
Adenosine stimulates the recruitment of endothelial progenitor cells to the ischemic heart Involvement of the microrna-150-cxcr4-sdf-1α pathway Emeline Goretti, MSc No conflict of interest Endothelial
More informationLXIV: DRUGS: 4. RAS BLOCKADE
LXIV: DRUGS: 4. RAS BLOCKADE ACE Inhibitors Components of RAS Actions of Angiotensin i II Indications for ACEIs Contraindications RAS blockade in hypertension RAS blockade in CAD RAS blockade in HF Limitations
More informationStructural abnormalities of the heart and vascular system in CKD & Dialysis - Thick but weak
Structural abnormalities of the heart and vascular system in CKD & Dialysis - Thick but weak Kerstin Amann Nephropathology, Dept. of Pathology, University of Erlangen-Nürnberg Krankenhausstr. 8-10 91054
More informationAT1 RECEPTOR BLOCKADE ATTENUATES INSULIN RESISTANCE AND MYOCARDIAL REMODELING IN RATS WITH DIET-INDUCED OBESITY
AT1 RECEPTOR BLOCKADE ATTENUATES INSULIN RESISTANCE AND MYOCARDIAL REMODELING IN RATS WITH DIET-INDUCED OBESITY SA Oliveira Jr, MP Okoshi, PF Martinez, DM Guizoni, BP Torres, M Dal Pai-Silva, K Okoshi,
More informationSupplementary Figure S I: Effects of D4F on body weight and serum lipids in apoe -/- mice.
Supplementary Figures: Supplementary Figure S I: Effects of D4F on body weight and serum lipids in apoe -/- mice. Male apoe -/- mice were fed a high-fat diet for 8 weeks, and given PBS (model group) or
More informationThe Angiopoietin Axis in Cancer
Ang2 Ang1 The Angiopoietin Axis in Cancer Tie2 An Overview: The Angiopoietin Axis Plays an Essential Role in the Regulation of Tumor Angiogenesis Growth of a tumor beyond a limiting size is dependent upon
More informationTopically Applicable Stromal Cell Growth Factors - Encapsulated Cosmeceuticals
Topically Applicable Stromal Cell Growth Factors - Encapsulated Cosmeceuticals Stem cells move to injured area, differentiate into neighboring cells, and replace the damaged cells Cell Eons Stem cells
More informationSupplementary Figure 1:
Supplementary Figure 1: (A) Whole aortic cross-sections stained with Hematoxylin and Eosin (H&E), 7 days after porcine-pancreatic-elastase (PPE)-induced AAA compared to untreated, healthy control aortas
More informationΚΑΡΔΙΑΚΗ ΑΝΕΠΑΡΚΕΙΑ ΚΑΙ ΑΝΤΑΓΩΝΙΣΤΕΣ ΑΛΔΟΣΤΕΡΟΝΗΣ ΣΠΥΡΟΜΗΤΡΟΣ ΓΕΩΡΓΙΟΣ MD, FESC. E.Α Κ/Δ Γ.Ν.ΚΑΤΕΡΙΝΗΣ
ΚΑΡΔΙΑΚΗ ΑΝΕΠΑΡΚΕΙΑ ΚΑΙ ΑΝΤΑΓΩΝΙΣΤΕΣ ΑΛΔΟΣΤΕΡΟΝΗΣ ΣΠΥΡΟΜΗΤΡΟΣ ΓΕΩΡΓΙΟΣ MD, FESC. E.Α Κ/Δ Γ.Ν.ΚΑΤΕΡΙΝΗΣ Aldosterone is a mineralocorticoid hormone synthesized by the adrenal glands that has several regulatory
More informationSupplemental Figure I
Supplemental Figure I Kl ( mmol/l)-induced Force orta M (mn) 1 (mn) 1 Supplemental Figure I. Kl-induced contractions. and, Kl ( mmol/l)-induced contractions of the aorta () and those of mesenteric arteries
More informationSupplemental Table 1. Primer sequences for transcript analysis
Supplemental Table 1. Primer sequences for transcript analysis Primer Sequence (5 3 ) Primer Sequence (5 3 ) Mmp2 Forward CCCGTGTGGCCCTC Mmp15 Forward CGGGGCTGGCT Reverse GCTCTCCCGGTTTC Reverse CCTGGTGTGCCTGCTC
More informationMyocardial fibrosis is a pathological feature associated
Angiotensin II Type 2 Receptor Is Essential for Left Ventricular Hypertrophy and Cardiac Fibrosis in Chronic Angiotensin II Induced Hypertension Sahoko Ichihara, MD; Takaaki Senbonmatsu, MD, PhD; Edward
More informationEffects of the angiotensin II type-1 receptor antagonist telmisartan on endothelial activation induced by advanced glycation endproducts
Effects of the angiotensin II type-1 receptor antagonist telmisartan on endothelial activation induced by advanced glycation endproducts Serena Del Turco, Teresa Navarra, Giuseppina Basta, Raffaele De
More informationAngiostasis and Angiogenesis Regulated by Angiopoietin1-Tie2 Receptor System
Japan-Mexico Workshop on Pharmacology and Nanobiology Feb. 25, 2009; Universidad Nacional Autönoma de Mëxico, Mexico City Angiostasis and Angiogenesis Regulated by Angiopoietin1-Tie2 Receptor System Shigetomo
More informationRole of Inflammation in Pulmonary Hypertension
Role of Inflammation in Pulmonary Hypertension K. R. Stenmark University of Colorado Denver, USA Prominent Fibroproliferative Changes are Observed in the Lung Vasculature of Infants With Pulmonary Arterial
More informationCNS Effects of Aldosterone :
CNS Effects of Aldosterone : Critical Roles in salt-sensitive sensitive hypertension and CHF. Frans HH Leenen MD, PhD, FRCPC, FAHA 2 Renin Angiotensin Aldosterone System Circulatory RAAS Tissue RAAS: -
More information(PDGF), 9 ( -2 (FGF-2), SMO
Abstract An ethanol extract from shark muscle has been shown to have potent angiogenic activity when mixed together with olive oil in a ratio of 1part extract to 9 parts olive oil. This mixture has been
More informationReperfusion Injury: How Can We Reduce It?
MI/CAD: Practical Question in Management of AMI Patients Reperfusion Injury: How Can We Reduce It? Hyun-Jai Cho, M.D., Ph.D Cardiovascular Center & Department of Internal Medicine Seoul National University
More informationBlood Vessels. Dr. Nabila Hamdi MD, PhD
Blood Vessels Dr. Nabila Hamdi MD, PhD ILOs Understand the structure and function of blood vessels. Discuss the different mechanisms of blood pressure regulation. Compare and contrast the following types
More informationDoppler ultrasound, see Ultrasonography. Magnetic resonance imaging (MRI), kidney oxygenation assessment 75
Subject Index Acidemia, cardiorenal syndrome type 3 146 Acute Dialysis Quality Initiative (ADQI) acute kidney injury biomarkers, see Acute kidney injury; specific biomarkers cardiorenal syndrome, see specific
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More informationCELL BIOLOGY - CLUTCH CH CELL JUNCTIONS AND TISSUES.
!! www.clutchprep.com CONCEPT: CELL-CELL ADHESION Cells must be able to bind and interact with nearby cells in order to have functional and strong tissues Cells can in two main ways - Homophilic interactions
More informationSUPPLEMENTARY FIG. S5. ROS regulated the signaling responses of A. gambiae 4a3B cells to human insulin. (A) 4a3B cells were stimulated with 6000
Supplementary Data SUPPLEMENTARY FIG. S1. Exogenous H 2 O 2 induced rapid activation of ERK in Anopheles stephensi cells. ASE cells were treated with PBS or with 500 mmh 2 O 2 for 5, 30, 60, and 180 min.
More informationulcer healing role 118 Bicarbonate, prostaglandins in duodenal cytoprotection 235, 236
Subject Index Actin cellular forms 48, 49 epidermal growth factor, cytoskeletal change induction in mucosal repair 22, 23 wound repair 64, 65 polyamine effects on cytoskeleton 49 51 S-Adenosylmethionine
More informationRecovery of Myocardial Infarction via Unique Modulation of the Cardiac Microenvironment
2016 춘계심혈관통합학술대회, 경주 Recovery of Myocardial Infarction via Unique Modulation of the Cardiac Microenvironment Youngkeun Ahn, MD, PhD Department of Cardiology, Cardiovascular Center Chonnam National University
More informationRisk Stratification in Heart Failure: The Role of Emerging Biomarkers
Risk Stratification in Heart Failure: The Role of Emerging Biomarkers David G. Grenache, PhD Associate Professor of Pathology, University of Utah Medical Director, ARUP Laboratories Salt Lake City, UT
More informationHealing and Repair. Dr. Nabila Hamdi MD, PhD
Healing and Repair Dr. Nabila Hamdi MD, PhD 1 ILOs Know the classification of human cells according to their ability for proliferation. Understand the mechanism of cellular regeneration. Identify the types
More informationCYTOKINE RECEPTORS AND SIGNAL TRANSDUCTION
CYTOKINE RECEPTORS AND SIGNAL TRANSDUCTION What is Cytokine? Secreted popypeptide (protein) involved in cell-to-cell signaling. Acts in paracrine or autocrine fashion through specific cellular receptors.
More informationSestrin2 and BNIP3 (Bcl-2/adenovirus E1B 19kDa-interacting. protein3) regulate autophagy and mitophagy in renal tubular cells in. acute kidney injury
Sestrin2 and BNIP3 (Bcl-2/adenovirus E1B 19kDa-interacting protein3) regulate autophagy and mitophagy in renal tubular cells in acute kidney injury by Masayuki Ishihara 1, Madoka Urushido 2, Kazu Hamada
More informationIntroduction: 年 Fas signal-mediated apoptosis. PI3K/Akt
Fas-ligand (CD95-L; Fas-L) Fas (CD95) Fas (apoptosis) 年 了 不 度 Fas Fas-L 力 不 Fas/Fas-L T IL-10Fas/Fas-L 不 年 Fas signal-mediated apoptosis 度降 不 不 力 U-118, HeLa, A549, Huh-7 MCF-7, HepG2. PI3K/Akt FasPI3K/Akt
More informationBiomarkers in cardiovascular disease. Felix J. Rogers, DO, FACOI April 29, 2018
Biomarkers in cardiovascular disease Felix J. Rogers, DO, FACOI April 29, 2018 Biomarkers NIH: A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biological
More informationC-Phycocyanin (C-PC) is a n«sjfc&c- waefc-jduble phycobiliprotein. pigment isolated from Spirulina platensis. This water- soluble protein pigment is
' ^Summary C-Phycocyanin (C-PC) is a n«sjfc&c- waefc-jduble phycobiliprotein pigment isolated from Spirulina platensis. This water- soluble protein pigment is of greater importance because of its various
More informationEstrogens vs Testosterone for cardiovascular health and longevity
Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in
More informationRenal angiotensin II up-regulation and myofibroblast activation in human membranous nephropathy
Kidney International, Vol. 64, Supplement 86 (2003), pp. Renal angiotensin II up-regulation and myofibroblast activation in human membranous nephropathy SERGIO A. MEZZANO, CLAUDIO A. AROS, ALEJANDRA DROGUETT,
More informationAngiotensin-Converting Enzyme-2 Overexpression Improves Left Ventricular Remodeling and Function in a Rat Model of Diabetic Cardiomyopathy
Journal of the American College of Cardiology Vol. 59, No. 8, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.09.071
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature10188 Supplementary Figure 1. Embryonic epicardial genes are down-regulated from midgestation stages and barely detectable post-natally. Real time qrt-pcr revealed a significant down-regulation
More informationKlotho: renal and extra-renal effects
Klotho: renal and extra-renal effects Juan F. Navarro-González, MD, PhD, FASN Nephrology Service and Research Division University Hospital Nuestra Señora de Candalaria Santa Cruz de Tenerife. Spain Klotho:
More informationExtracellular matrix Basic and translational science: Highlights of the congress
Extracellular matrix Basic and translational science: Highlights of the congress Stephane Heymans, Maastricht University Medical Centre, CARIM, Netherlands Speaker The extracellular matrix modulates cardiac
More informationROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret
ROLE OF INFLAMMATION IN HYPERTENSION Dr Barasa FA Physician Cardiologist Eldoret Outline Inflammation in CVDs the evidence Basic Science in Cardiovascular inflammation: The Main players Inflammation as
More informationSupplemental Figure 1. Western blot analysis indicated that MIF was detected in the fractions of
Supplemental Figure Legends Supplemental Figure 1. Western blot analysis indicated that was detected in the fractions of plasma membrane and cytosol but not in nuclear fraction isolated from Pkd1 null
More informationJ Jpn Coll Angiol, 2009, 49:
Online publication October 6, 2009 48 2 20 J Jpn Coll Angiol, 2009, 49: 293 297 atrial natriuretic peptide, brain natriuretic peptide, guanylyl cyclase-a receptor, cardiac remodeling, cardiac hypertrophy
More informationArteriosclerosis & Atherosclerosis
Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,
More informationHYPERTENSIVE VASCULAR DISEASE
HYPERTENSIVE VASCULAR DISEASE Cutoffs in diagnosing hypertension in clinical practice sustained diastolic pressures >90 mm Hg, or sustained systolic pressures >140 mm Hg Malignant hypertension A small
More informationRegenerative Medicine for Sclerotic Disorders
Regenerative Medicine Regenerative Medicine for Sclerotic Disorders JMAJ 7(7): 3 37, Toshikazu NAKAMURA rofessor, Division of Molecular Regenerative Medicine, Course of Advanced Medicine, Osaka University
More informationProtein kinase A mediated stimulation of activating transcription factor 3 by hypertrophic stimuli in cardiomyocytes
Protein kinase A mediated stimulation of activating transcription factor 3 by hypertrophic stimuli in cardiomyocytes Elina Koivisto, MD, PhD Institute of Biomedicine, Department of Pharmacology and Toxicology
More informationLeft ventricular hypertrophy: why does it happen?
Nephrol Dial Transplant (2003) 18 [Suppl 8]: viii2 viii6 DOI: 10.1093/ndt/gfg1083 Left ventricular hypertrophy: why does it happen? Gerard M. London Department of Nephrology and Dialysis, Manhes Hospital,
More informationINTRODUCTION. Induction of Monocyte Chemoattractant Protein-1 (MCP-1) Expression by Angiotensin II (AngII) in the Pancreatic Islets and Beta Cells
Induction of Monocyte Chemoattractant Protein-1 (MCP-1) Expression by Angiotensin II (AngII) in the Pancreatic Islets and Beta Cells Galina Chipitsyna, Qiaoke Gong, Chance F. Gray et al. Endocrinology,
More informationROMANIAN ACADEMY INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU. PhD THESIS Summary
ROMANIAN ACADEMY INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU PhD THESIS Summary INVOLVEMENT OF ALARMIN HMGB1 IN INFLAMMATORY PROCESSES ASSOCIATED WITH VASCULAR DYSFUNCTION IN HYPERLIPIDEMIA
More informationNiki Prakoura. Calreticulin upregulation in renal fibrosis
Calreticulin upregulation in renal fibrosis Niki Prakoura Section of Histology, Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece EuroKUP meeting, Madrid,
More informationPhospholipase C γ Prof. Graham Carpenter
Graham Carpenter, h.d. rofessor of Biochemistry Cornelia Crooke Department of Biochemistry Vanderbilt University School of Medicine, Nashville, TN 1 Receptor Tyrosine Kinases GF Extracellular M Intracellular
More informationFOCUS ON CARDIOVASCULAR DISEASE
The Consequences of Vitamin D Deficiency: FOCUS ON CARDIOVASCULAR DISEASE Vitamin D deficiency is a global health problem. With all the medical advances of the century, vitamin D deficiency is still epidemic.
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION Supplementary Figure 1. Long-term protection studies. 45 minutes of ischemia was induced in wild type (S1pr2 +/+ ) and S1pr2 -/- by MCAO. A) 5 days later brains were harvested
More informationPrevious experimental evidence indicates that some cardiovascular
Report Downloaded from http://circres.ahajournals.org/ by guest on July 1, 2018 Autocrine Stimulation of Cardiac Na -Ca 2 Exchanger Currents by Endogenous Endothelin Released by Angiotensin II Ernesto
More informationDr. Hany M. Abo-Haded
BY Dr. Hany M. Abo-Haded Pediatric Cardiology Unit, Mansoura Universty Children Hospital, Mansoura, Egypt Co-authors: Dina S El-Agamy and Mohamed A Elkablawy Background Doxorubicin (DOX) is an anthracycline
More informationClassification of Endothelial Dysfunction. Stefano Taddei Department of Internal Medicine University of Pisa, Italy
Classification of Endothelial Dysfunction Stefano Taddei Department of Internal Medicine University of Pisa, Italy Pathogenesis of atherosclerosis from endothelial dysfunction to clinical disease endothelial
More informationAcute coronary syndrome. Dr LM Murray Chemical Pathology Block SA
Acute coronary syndrome Dr LM Murray Chemical Pathology Block SA13-2014 Acute myocardial infarction (MI) MI is still the leading cause of death in many countries It is characterized by severe chest pain,
More informationBlood pressure control Contin. Reflex Mechanisms. Dr. Hiwa Shafiq
Blood pressure control Contin. Reflex Mechanisms Dr. Hiwa Shafiq 17-12-2018 A. Baroreceptor reflexes Baroreceptors (stretch receptors) located in the walls of several large systemic arteries( specially
More informationSupplemental Materials
Supplemental Methods Spin trap and electron paramagnetic resonance spectroscopy Hypoxanthine (1 mmol=l) plus xanthine oxidase (.1 u=ml) were incubated in Krebs solution at 378C bubbled with 95% O 2 and
More informationInsulin Resistance. Biol 405 Molecular Medicine
Insulin Resistance Biol 405 Molecular Medicine Insulin resistance: a subnormal biological response to insulin. Defects of either insulin secretion or insulin action can cause diabetes mellitus. Insulin-dependent
More informationשינויים מולקולאריים ומבניים באי ספיקת לב אפשרויות לטיפול עתידני
שינויים מולקולאריים ומבניים באי ספיקת לב אפשרויות לטיפול עתידני פרופ יהונתן ליאור 1 Braunwald s Heart Disease 8th Edition Chapter 21 Mechanisms of Cardiac Contraction and Relaxation Chapter 22 Pathophysiology
More informationThe Process of Angiogenesis & Inhibition of Angiogenesis and/or Lymphangiogenesis
The Process of Angiogenesis & Inhibition of Angiogenesis and/or Lymphangiogenesis Nam Deuk Kim, Ph.D. Pusan National University Contents Part 1. The process of angiogenesis Part 2. The role of angiopoietins
More informationClinical application of Arterial stiffness. pulse wave analysis pulse wave velocity
Clinical application of Arterial stiffness pulse wave analysis pulse wave velocity Arterial system 1. Large arteries: elastic arteries Aorta, carotid, iliac, Buffering reserve: store blood during systole
More informationNFκB What is it and What s the deal with radicals?
The Virtual Free Radical School NFκB What is it and What s the deal with radicals? Emily Ho, Ph.D Linus Pauling Institute Scientist Department of Nutrition and Food Management Oregon State University 117
More informationCell therapy: enhancing the therapeutic potential of cardiac progenitors for delivery post myocardial infarction. Rita Alonaizan
Cell therapy: enhancing the therapeutic potential of cardiac progenitors for delivery post myocardial infarction Rita Alonaizan Department of Physiology, Anatomy & Genetics St Catherine s College Supervisor:
More informationThe Beneficial Role of Angiotensin- Converting Enzyme Inhibitor in Acute Myocardial Infarction
The Beneficial Role of Angiotensin- Converting Enzyme Inhibitor in Acute Myocardial Infarction Cardiovascular Center, Korea University Guro Hospital 2007. 4. 20 Seung-Woon Rha, MD, PhD Introduction 1.
More informationIntegrin v 3 targeted therapy for Kaposi s sarcoma with an in vitro evolved antibody 1
Integrin v 3 targeted therapy for Kaposi s sarcoma with an in vitro evolved antibody 1 CHRISTOPH RADER, 2 MIKHAIL POPKOV, JOHN A. NEVES, AND CARLOS F. BARBAS III 2 Department of Molecular Biology and The
More informationResearch Article Cytological Evaluation of Hyaluronic Acid on Wound Healing Following Extraction
Cronicon OPEN ACCESS DENTAL SCIENCE Research Article Cytological Evaluation of Hyaluronic Acid on Wound Healing Following Extraction Gocmen Gokhan 1 *, Gonul O 1, Oktay NS 2, Pisiriciler R 2 and Goker
More informationCirculation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.
Circulation Blood Pressure and Antihypertensive Medications Two systems Pulmonary (low pressure) Systemic (high pressure) Aorta 120 mmhg Large arteries 110 mmhg Arterioles 40 mmhg Arteriolar capillaries
More informationGrowth Factors. BIT 230 Walsh Chapter 7
Growth Factors BIT 230 Walsh Chapter 7 3 Definitions Autocrine: a mode of hormone action in which a hormone affects the function of the cell type that produced it. Paracrine: Relating to the release of
More informationEndothelial PGC 1 - α 1 mediates vascular dysfunction in diabetes
Endothelial PGC-1α mediates vascular dysfunction in diabetes Reporter: Yaqi Zhou Date: 04/14/2014 Outline I. Introduction II. Research route & Results III. Summary Diabetes the Epidemic of the 21st Century
More informationTitle:Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells
Author's response to reviews Title:Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells Authors: Ingvild J Brusevold (i.j.brusevold@medisin.uio.no) Ingun H Tveteraas
More informationC57BL/6 Mice are More Appropriate. than BALB/C Mice in Inducing Dilated Cardiomyopathy with Short-Term Doxorubicin Treatment
Original Article C57BL/6 Mice are More Appropriate Acta Cardiol Sin 2012;28:236 240 Heart Failure & Cardiomyopathy C57BL/6 Mice are More Appropriate than BALB/C Mice in Inducing Dilated Cardiomyopathy
More informationTissue renewal and Repair. Nisamanee Charoenchon, PhD Department of Pathobiology, Faculty of Science
Tissue renewal and Repair Nisamanee Charoenchon, PhD Email: nisamanee.cha@mahidol.ac.th Department of Pathobiology, Faculty of Science Topic Objectives 1. Describe processes of tissue repair, regeneration
More informationEffect of Sodium Loading and Depletion on Cyclic Nucleotides in Plasma and Aorta. Interaction between Prostacyclin and Cyclic Nucleotides
Endocrinol. Japon. 1982, 29 (2), 245-250 Effect of Sodium Loading and Depletion on Cyclic Nucleotides in Plasma and Aorta. Interaction between Prostacyclin and Cyclic Nucleotides MANABU YOSHIMURA, TERUO
More informationAntialdosterone treatment in heart failure
Update on the Treatment of Chronic Heart Failure 2012 Antialdosterone treatment in heart failure 전남의대윤현주 Chronic Heart Failure Prognosis of Heart failure Cecil, Text book of Internal Medicine, 22 th edition
More informationIschaemic Preconditioning prevents the differentiation induced by ischaemia/reperfusion injury of rat cardiac fibroblast to myofibroblast
Ischaemic Preconditioning prevents the differentiation induced by ischaemia/reperfusion injury of rat cardiac fibroblast to myofibroblast Kartika Pertiwi1 and Lisa Chilton2 1: Biology Education Department,
More informationDOWNLOAD PDF CARDIAC REMODELING AND CELL DEATH IN HEART FAILURE
Chapter 1 : The fibrosis-cell death axis in heart failure Remodeling may be defined as changes in the morphology, structure, and function of the heart related to alterations in loading conditions and/or
More informationVWF other roles than hemostasis. Summary 1: VWF & hemostasis synthesis 11/4/16. Structure/function relationship & functions kDa.
VWF other roles than hemostasis Len$ng PJ, Casari C et al JTH 2012 Summary 1: VWF & hemostasis synthesis Structure/function relationship & functions (HMWM) 20.000kDa multimerization propeptide FVIII GPIb
More informationTarget Protein Antibody name Product number Manufacturer Species Epitope Dilution Aggrecan Anti-aggrecan AB1031 EMD Millipore Corp Rabbit
Family history Hypertension/ Maximum Degree of aortic Bicuspid Disease Age/Sex Diagnosed CTD of aortic disease Treated aortic insufficiency/stenosis aortic Aneurysm 63/M No Yes Yes/Yes diameter 59mm 1-2+/None
More informationStewart et al. CD36 ligands promote sterile inflammation through assembly of a TLR 4 and 6 heterodimer
NFκB (fold induction) Stewart et al. ligands promote sterile inflammation through assembly of a TLR 4 and 6 heterodimer a. mrna (fold induction) 5 4 3 2 1 LDL oxldl Gro1a MIP-2 RANTES mrna (fold induction)
More informationReceptor mediated Signal Transduction
Receptor mediated Signal Transduction G-protein-linked receptors adenylyl cyclase camp PKA Organization of receptor protein-tyrosine kinases From G.M. Cooper, The Cell. A molecular approach, 2004, third
More information